These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 27580616
1. Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis. Bokhari S, Morgenstern R, Weinberg R, Kinkhabwala M, Panagiotou D, Castano A, DeLuca A, Kontak A, Jin Z, Maurer MS. J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616 [Abstract] [Full Text] [Related]
2. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. JAMA Cardiol; 2016 Nov 01; 1(8):880-889. PubMed ID: 27557400 [Abstract] [Full Text] [Related]
9. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. Circ Cardiovasc Imaging; 2013 Mar 01; 6(2):195-201. PubMed ID: 23400849 [Abstract] [Full Text] [Related]
10. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi. Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H. J Cardiol; 2021 Feb 01; 77(2):124-130. PubMed ID: 33132078 [Abstract] [Full Text] [Related]
12. Comparison of 1-h with 3-h planar 99mTc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard. Saitou T, Aikawa T, Manabe O, Nagase A, Kudo T, Oyama-Manabe N. Ann Nucl Med; 2023 Feb 01; 37(2):99-107. PubMed ID: 36352186 [Abstract] [Full Text] [Related]
14. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study. Pandey S, Teruya S, Rodriguez C, Deluca A, Kinkhabwala M, Johnson LL, Fine D, Sabogal N, Winburn M, Castillo M, Bhatia K, Malkovskaya R, Raiszadeh F, Kurian D, Miller EJ, Einstein AJ, Maurer MS, Ruberg FL. J Nucl Cardiol; 2023 Aug 01; 30(4):1414-1419. PubMed ID: 36823486 [Abstract] [Full Text] [Related]
17. Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis. Guo H, Wu S, Xiang X, Wang S, Fang Z, Ye Q, Zou Y, Wang Y, Peng D, Ma X. Ann Nucl Med; 2024 Apr 01; 38(4):288-295. PubMed ID: 38252229 [Abstract] [Full Text] [Related]
19. Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging. Takasone K, Katoh N, Takahashi Y, Abe R, Ezawa N, Yoshinaga T, Yanagisawa S, Yazaki M, Oguchi K, Koyama J, Sekijima Y. Amyloid; 2020 Dec 01; 27(4):266-274. PubMed ID: 32722948 [Abstract] [Full Text] [Related]
20. New quantitative indices of cardiac amyloidosis with 99mTc-pyrophosphate scintigraphy. Matsuda N, Otsuka H, Otani T, Azane S, Kunikane Y, Otomi Y, Ueki Y, Kubota M, Amano M, Yagi S, Sata M, Harada M. Jpn J Radiol; 2023 Apr 01; 41(4):428-436. PubMed ID: 36449252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]